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A ﬂipping permease
 
ipid bilayers should be a no-flipping zone for integral 
membrane proteins, with the hydrophobicity blocking 
any cross-membrane excursions. But now Mikhail  L
 
Bogdanov, Phillip Heacock, and William 
Dowhan (University of Texas, Houston, TX) 
report that fully synthesized lactose permease 
(LacY) can reverse orientation when the lipid 
composition of the membrane is changed.
Dowhan focused on phosphatidylethanolamine 
(PE), which is the only zwitterionic lipid in 
 
Escherichia coli
 
 (the other lipids all have anionic 
head groups). He knew that PE was needed for 
LacY activity in vitro, and found that the same was 
true in vivo. Mutant 
 
E. coli
 
 lacking PE made a 
version of LacY that allowed facilitated but not 
active transport of lactose. This aberrant LacY had 
half of its 12 transmembrane domains in a config-
uration opposite to that of normal LacY. But when 
PE synthesis was induced in the absence of new 
LacY synthesis, the existing LacY flipped back into 
LacY (top) can flip orientations 
when deprived of a 
lipid (bottom).
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Attack of the microvesicles
 
elanoma cells send out microvesicles loaded with Fas ligand 
(FasL) to kill their would-be assassins, according to Stefano 
Fais (Istituto Superiore di Sanità, Rome, Italy), Licia Rivoltini 
(Istituto Nazionale dei Tumori, Milan, Italy), and colleagues.
The FasL hijacks a normal transport pathway for melanin, the 
pigment that melanosomes load into microvesicles and send to 
neighboring keratinocytes. In melanoma cells, these microvesicles, 
or exosomes, are also loaded with FasL, which can trigger apoptosis 
in Fas-expressing immune cells that might otherwise counteract 
tumor growth.
This mechanism of counterattack may operate in other tumors, 
as microvesicles are released from a number of cell types. In the 
case of melanoma cells, the new work clears up a controversy. 
Microvesicles explain how melanoma cells can have an apoptotic 
effect (the initial observation) without expressing FasL on their 
cell surface (the subsequent, seemingly contradictory observation).
Although purified 
microvesicles can kill cultured 
Fas-expressing cells, the same 
cells are not killed by coculture 
with melanoma cells. This 
suggests that, in vivo, some 
other microenvironmental 
factors may either provoke a 
higher level of microvesicle 
production or optimize the 
effects of the killer exosomes. 
Fais also hopes to determine how the Fas-expressing melanoma cells 
manage to avoid killing themselves with their own microvesicles. 
 
 
 
Reference: 
 
Andreola, G., et al. 2002. 
 
J. Exp. Med.
 
 195:1303–1316.
M
Melanoma cells can attack 
using microvesicles loaded 
with FasL (red).
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The transcription–export link
 
ranscription is a congested 
business, with many different 
proteins crowding in to exert their 
influence. Now Katja Sträßer, Ed 
Hurt (University of Heidelberg, 
Germany), and colleagues have 
found that even nuclear export 
proteins get into the act, via an 
interaction with transcription 
elongation factors. The findings 
suggest that transcription, splicing 
and nuclear export are linked 
processes, and that there are many levels of regulation between 
these processes that remain to be discovered.
Hurt found that yeast protein Sub2, which with Yra1 
connects directly to mRNA exporters, binds a collection of 
proteins that make up the THO complex. This complex 
promotes transcription by acting on the elongation step.
The proposed connections were confirmed by synthetic 
lethal interactions, and with human homologues of the THO 
proteins. Hurt and colleagues named the combined complex 
the transcription–export or TREX complex, and found that 
proteins in the complex could be tracked by chromatin 
immunoprecipitation as they moved along a transcribed gene 
with RNA polymerase.
Mutants lacking a THO component had an mRNA export 
defect, but Hurt does not think that transcripts get posted 
directly from a gene into a nuclear pore complex. Transcription 
occurs throughout the nucleoplasm, and TREX factor binding at 
these sites may simply allow nuclear pores to capture mRNA–
protein complexes after they diffuse away from these sites.
 
 
 
 
 
Reference:  Sträßer, K., et al. 2002. 
 
Nature
 
. 10.1038/nature746.
T
Defects in a transcription 
elongation factor lead 
to problems in mRNA 
export (right).
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its native conformation, and could now do active transport.
The key to this change may lie in the weakly hydrophobic 
seventh transmembrane domain, which may flip out of the 
membrane or form a hairpin loop. Dowhan hopes 
to detect the direction of propagation of the 
change—where the flipping begins and ends—by 
blocking the process with a single large covalent 
modifier. He will also test whether the flipping 
requires reentry into the translocon machinery.
For LacY, the dependence on PE may be a 
structural accident. But other proteins function 
only in certain parts of the cell because of differing 
lipid environments. And for Dowhan, the result 
emphasizes the importance of lipids. “Everyone 
focuses on the proteins, and ignores the lipids, 
viewing them as a simple solvent,” he says. “But 
membrane protein sequences are written for a 
particular lipid environment.”
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